Searched for
SHARON BIO MEDICINE
Innova Captab IPO: Last day today. Check subscription status, GMP, other detailsInnova Captab IPO is a combination of fresh issue of equity shares worth up to Rs 400 crore, and an offer-for-sale (OFS) of up to 9,600,000...- Innova Captab IPO: Check subscription status, GMP, review, timelineInnova Captab IPO price band is fixed at Rs 426-448, and at the upper end, the company plans to raise Rs 570 crore. Investors can bid for 3...
- Innova Captab IPO fully subscribed at 1.40 times on Day 1. Check GMP, other detailsInnova Captab IPO: Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain in...
- Innova Captab IPO opens today: Should you subscribe?Innova Captab IPO is a combination of a fresh issue of equity shares worth up to Rs 400 crore, and an offer-for-sale (OFS) of up to 9,600,0...
- Innova Captab may be a good buy after a post-listing reviewInnova Captab IPO: The promoters Manoj Kumar Lohariwala and his brother Vinay Kumar Lohariwala are diluting their stakes from 67% to 52%. O...
- Sebi bars 7 entities from market for 3 yrs on insider trading in Sharon Bio-Medicine sharesIndia's Securities and Exchange Board has banned seven companies, including Bharat Mohanlal Mehta, Impressive Trading and Lalita Bharat Meh...
- NCLT approves Innova Captab's resolution plan for Sharon BioThe Mumbai bench of the National Company Law Tribunal (NCLT) has approved ₹256.4 crore resolution plan of Innova Captab for Sharon Bio Medi...
- Piramal, Cadila among 32 companies in race to buy Sharon Bio-MedicineSome fund houses, including iLabs India Special Situations Fund, Edelweiss Alternative Assets Advisors, Capri Global Holdings, ACRE India, ...
- 145 firms under additional surveillance measure framework: BSEPublic sector enterprises and public sector banks are excluded from the ASM framework.
- Sensex up; Dishman Pharma, Cimmco, Shakti Pumps among stocks that hit fresh 52-week high in tradeThe NSE Nifty index was trading 56.65 points up at 9,101.85 in the afternoon trade on Tuesday following firm global cues.
- Sharon Bio-Medicine gets USFDA nod for API plant in TalojaThe inspection was conducted during June 29, 2015 to July 7, 2015 at the Taloja plant, it added.
- Sharon Bio-Medicine jumps 20% as board discusses strategy to turnaroundThe company has reported standalone losses in at least past four quarter. For the March quarter, it reported a widening of standalone profi...
- Twelve stocks in focus on Wednesday, 22 June 2016The Indian market is expected to open flat. Here is a list of top twelve stocks that are likely to be in focus today.
- Pharma stocks continue to remain under pressureShares of Venus Remedies tumbled 5.90 per cent, Lupin was down 4.23 per cent and Natco Pharma dipped 3.23 per cent on BSE.
- Sharon receives EIR report from USFDA on inspection closureSharon Bio-Medicine said it has received the establishment inspection report (EIR) from the USFDA on closure of inspection of its Dehradun ...
- Twelve stocks in focus in Wednesday's tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.
- USFDA inspects Sharon Bio-Medicine's Dehradun-based plantLast month, USFDA had issued a warning letter to the firm for failing to pay generic drug user fee by its owner for three years starting 20...
- USFDA inspects Sharon Bio-Medicine's Taloja unitOne of the company's unit located at Taloja in Raigad district in Maharashtra has been inspected and audited by United States FDA.
- USFDA issues warning letter to Sharon Bio-medicineThe US regulator has issued a warning letter to Sharon Bio-medicine for failing to pay generic drug user fee by its owner for three years.
- Sharon Bio September quarter profit up 23.65 pc at Rs 11.97 crDrug firm Sharon Bio-Medicine today said its net profit rose by 23.65 per cent to Rs 11.97 crore for the quarter ended September 30, 2012 o...
Load More
